Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Biomerica launches gastrointestinal disease test:

This article was originally published in Clinica

Executive Summary

Biomerica has added to its line of gastrointestinal disease tests with the launch of Pepgen, an ELISA-based test for pepsinogen-I in plasma. Pepsinogen-I is a precursor of the proteolytic enzyme pepsin. Its concentration in plasma is elevated in patients with peptic ulcers, but depressed in patients with gastric cancer. The new test, which can be used in small laboratories with minimal equipment or automated on a laboratory analyser, can thus be used to distinguish between the two conditions. It is available through Biomerica's distributor network in over 40 countries.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT077007

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel